---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-25-051362"
form_type: "8-K"
ticker: "TMCI"
cik: "0001630627"
company_name: "TREACE MEDICAL CONCEPTS, INC."
filed_at: "2025-04-07T23:59:59+00:00"
generated_at: "2026-05-23T19:42:54.834817+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.35
calibrated_materiality_score: 0.35
confidence: "high"
source: SEC EDGAR
---

# James Treace to retire from board; CEO John Treace appointed chairman effective May 20, 2025

## Summary
- James T. Treace to retire from board at 2025 annual meeting (expected May 20, 2025); departure not related to any disagreement.
- Board appoints CEO & Founder John T. Treace as Chairman, effective immediately after the 2025 annual meeting.
- Board size decreases from nine to eight directors upon James Treace's retirement.
- Lead independent director Richard W. Mott will continue in his role.
- No change in John T. Treace's compensation in connection with appointment.

## SEC filing metadata
- accession: 0000950170-25-051362
- form_type: 8-K
- ticker: TMCI
- cik: 0001630627
- company_name: TREACE MEDICAL CONCEPTS, INC.
- filed_at: 2025-04-07T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.35
- calibrated_materiality_score: 0.35
- confidence: high
- sec_items: 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1630627/000095017025051362/0000950170-25-051362-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1630627/000095017025051362/tmci-20250407.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-25-051362
- JSON: https://secwatch.observer/filing/0000950170-25-051362.json
- Plain text: https://secwatch.observer/filing/0000950170-25-051362.txt

## Key facts
- Executive change
  John T. Treace was appointed as Chairman of the Board at TREACE MEDICAL CONCEPTS, INC..
  - Action: appointed
  - Role: Chairman of the Board
  source text: appoint John T. Treace to serve as Chairman of the Board, effective upon the expiration of James T. Treace’s current term at the Company’s 2025 Annual Meeting.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1630627/000095017025051362/0000950170-25-051362-index.htm
- Executive change
  James T. Treace retired as Director at TREACE MEDICAL CONCEPTS, INC..
  - Action: retired
  - Role: Director
  source text: his intent to retire from the Board at the expiration of his current term at the 2025 annual meeting of stockholders
  evidence_url: https://www.sec.gov/Archives/edgar/data/1630627/000095017025051362/0000950170-25-051362-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.